Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
fhjfkkR7NzPTcjUq